FDA, ecology
FDA OKs First Biosimilar
FDA OKs First Biosimilar
Tracy Vence | Mar 6, 2015
The US Food and Drug Administration approves Sandoz’s Zarxio, a biosimilar to Amgen’s filgrastim, which is mainly prescribed for cancer patients.
HHS Rolls Out Public Access Plans
HHS Rolls Out Public Access Plans
Tracy Vence | Mar 3, 2015
The US Department of Health and Human Services outlines how the National Institutes of Health and its other agencies will make research results public.
Capsule Reviews
Capsule Reviews
Bob Grant | Mar 1, 2015
Evolving Ourselves, The Man Who Touched His Own Heart, Bats, and The Invaders
FDA OKs 23andMe Test
FDA OKs 23andMe Test
Kerry Grens | Feb 20, 2015
The US Food and Drug Administration will allow the personal genomics company to resume a disease-risk analysis.
Clinic Trial Problems Kept Mum
Clinic Trial Problems Kept Mum
Kerry Grens | Feb 11, 2015
Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.
FDA Head Leaving Post
FDA Head Leaving Post
Kerry Grens | Feb 6, 2015
US Food and Drug Administration commissioner Margaret Hamburg is stepping down after six years on the job.
Lazarus Drugs
Lazarus Drugs
Kate Yandell | Feb 1, 2015
While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.
 
Taming Bushmeat
Taming Bushmeat
Jyoti Madhusoodanan | Jan 1, 2015
Chinese farmers’ efforts at rearing wild animals may benefit conservation and reduce human health risks.
Science Setbacks: 2014
Science Setbacks: 2014
Molly Sharlach | Dec 25, 2014
This year in life science was marked by paltry federal funding increases, revelations of sequence contamination, and onerous regulations.
Top Science Scandals of 2014
Top Science Scandals of 2014
Jef Akst | Dec 25, 2014
The stem cell that never was; post-publication peer review website faces legal trouble; biosecurity breaches at federal labs